Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, today announced access to the most common compounded GLP-1 subscriptions for as low as $99 a month for eligible U.
Buying a new pharmacy will allow Hims & Hers to expand into new markets. Hims & Hers ( HIMS -1.11%) recently acquired a ...
Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...
Last week’s 19% gain means that institutional investors were on the positive end of the spectrum even as the company has ...
The biggest news was Hims & Hers issuing 976,341 shares of common stock to acquire Nivagen Pharmaceuticals, which does ...
Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $16.57 which represents a slight increase of $0.75 or 4.74% from the prior close of $15.82. The stock opened at $16.25 and ...
Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments ...
HIMS},has experienced notable fluctuations in its stock performance this year. Despite a remarkable rise in share prices, ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
As of 16 September at 10:38 am GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.
This summary of recent health news includes U.S. Senator Bernie Sanders advocating for cheaper Ozempic, new findings on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback